AGÕæÈ˹ٷ½

STOCK TITAN
  1. Home
  2. Sec-filings
  3. MBRX
  4. [8-K] Moleculin Biotech, Inc. Reports Material Event

[8-K] Moleculin Biotech, Inc. Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K

Filing content is currently unavailable.

Source:

Stock MBRX logo
Moleculin Biotec

NASDAQ:MBRX

MBRX Rankings

#5818 Ranked by Market Cap
N/A Ranked by Dividends

MBRX Latest News

Aug 28, 2025
Moleculin Announces Exercise of Warrants for $6.0 Million Gross Proceeds
Aug 27, 2025
Moleculin Issues New Positive AML Overall Survival Data:
Aug 14, 2025
Moleculin to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech
Aug 13, 2025
Moleculin Reports Second Quarter 2025 Financial Results and Highlights
Aug 6, 2025
Moleculin Biotech, Inc. Unveils Promising Preclinical Data of Annamycin in Liver Cancer Treatment

MBRX Latest SEC Filings

Aug 27, 2025
[8-K] Moleculin Biotech, Inc. Reports Material Event
Aug 18, 2025
[8-K] Moleculin Biotech, Inc. Reports Material Event
Aug 18, 2025
[8-K] Moleculin Biotech, Inc. Reports Material Event
Aug 14, 2025
[SCHEDULE 13G/A] Moleculin Biotech, Inc. SEC Filing
Aug 13, 2025
[8-K] Moleculin Biotech, Inc. Reports Material Event

MBRX Stock Data

16.48M
29.22M
3.52%
1.43%
13.45%
Biotechnology
Pharmaceutical Preparations
United States
HOUSTON